The Debate Over Embryonic Stem Cell Research - 1543 Words

While embryonic stem cell research has been ongoing for more than 30 years, it has only become a controversial topic over the past decade. The embryonic stem cell was first isolated in 1981 by two scientists at the University of Cambridge. However, it wasn’t until 1998 at the University of Wisconsin, Madison, where the first batch of embryonic stem cells were created in a test tube. In 2001, President George W. Bush approved the use of federal funding for research on this topic, following this action the stem cell controversy has been developing. The controversy around this topic focuses heavily on the ethical portion of stem cell research rather than the scientific evidence. Stem cell research has shown great promise for potentially†¦show more content†¦Therefore, much of the critic’s arguments are invalid due to the fact that the embryo won’t develop into a child. Stem cells are the beginning of an enormous scientific breakthrough, a breakthrough that critics are simply putting off. Embryonic stem cells have the potential to treat some of the worst diseases we face today, such as cancer. Many critics argue that adult stem cells offer a good alternative. However, adult stem cells have become specialized and only have the ability to become specific type of tissue. Unlike adult stem cells, embryonic stem cells have the ability to create any type of cell within the body, as well as replicate themselves. This difference is proof alone that embryonic stem cells are vital to treating the more complex illnesses. Due to this, embryonic stem cells would create a larger bank of replacement cells and tissues. This is important because although there is organ and tissue donation, there is a higher demand for them than we have to supply. With embryonic stem cells, there would be more available treatment for patients with diseases such as macular degeneration, spinal cord injuries, heart disease, and more. In the case of heart disease, with the use of embryonic stem cells, healthy heart tissue could be generated in the lab and then transplanted. This would lead to a quicker treatment option than waiting for an available tissue and organ through